{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T04:42:05Z","timestamp":1790484125984,"version":"4.1.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medicina Cl\u00ednica"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.medcli.2017.03.009","type":"journal-article","created":{"date-parts":[[2017,4,18]],"date-time":"2017-04-18T22:01:22Z","timestamp":1492552882000},"page":"331-338","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Etiolog\u00eda de la insuficiencia renal en pacientes con endocarditis infecciosa. Papel de los antibi\u00f3ticos"],"prefix":"10.1016","volume":"149","author":[{"given":"Miguel \u00c1ngel","family":"Goenaga S\u00e1nchez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xabier","family":"Kortajarena Urkola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilio","family":"Bouza Santiago","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Mu\u00f1oz Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Verde Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Carmen","family":"Fari\u00f1as \u00c1lvarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ram\u00f3n","family":"Teira Cobo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Manuel","family":"Peric\u00e1s Pulido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ar\u00edstides","family":"de Alarc\u00f3n Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dolores","family":"Sousa Regueiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josefa","family":"Ruiz Morales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Regino Jos\u00e9","family":"Rodr\u00edguez-\u00c1lvarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Antorrena Miranda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Antonio","family":"Iribarren Loyarte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.medcli.2017.03.009_bib0135","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1093\/ndt\/15.11.1782","article-title":"Renal pathological findings in infective endocarditis","volume":"15","author":"Majumdar","year":"2000","journal-title":"Nephrol Dial Transplant."},{"key":"10.1016\/j.medcli.2017.03.009_bib0140","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1038\/ki.2014.424","article-title":"Update on endocarditis-associated glomerulonephritis","volume":"87","author":"Boils","year":"2015","journal-title":"Kidney Int."},{"key":"10.1016\/j.medcli.2017.03.009_bib0145","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1093\/jac\/dkr450","article-title":"Guidelines for the diagnosis and antibiotic treatment of endocarditis in adults: A report of the Working Party of the British Society for Antimicrobial Chemotherapy","volume":"67","author":"Gould","year":"2012","journal-title":"J Antimicrob Chemother."},{"key":"10.1016\/j.medcli.2017.03.009_bib0150","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1093\/eurheartj\/ehp285","volume":"30","author":"Habib","year":"2009","journal-title":"Eur Heart J."},{"key":"10.1016\/j.medcli.2017.03.009_bib0155","first-page":"379","article-title":"Vancomycin nephrotoxicity: Myths and facts","volume":"69","author":"Gupta","year":"2011","journal-title":"Neth J Med."},{"key":"10.1016\/j.medcli.2017.03.009_bib0160","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1086\/594122","article-title":"Severity of gentamicin's nephrotoxic effect on patients with infective endocarditis: A prospective observational cohort study of 373 patients","volume":"48","author":"Buchholtz","year":"2009","journal-title":"Clin Infect Dis."},{"key":"10.1016\/j.medcli.2017.03.009_bib0165","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1093\/jac\/25.4.679","article-title":"Nephrotoxicity of vancomycin, alone and with an aminoglycoside","volume":"25","author":"Rybak","year":"1990","journal-title":"J Antimicrob Chemother."},{"key":"10.1016\/j.medcli.2017.03.009_bib0170","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1093\/jac\/dkl044","article-title":"The role of aminoglycosides in combination with a beta-lactam for the treatment of bacterial endocarditis: A meta-analysis of comparative trials","volume":"57","author":"Falagas","year":"2006","journal-title":"J Antimicrob Chemother."},{"key":"10.1016\/j.medcli.2017.03.009_bib0175","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1161\/CIRCULATIONAHA.112.001170","article-title":"Enterococcus faecalis infective endocarditis: A pilot study of the relationship between duration of gentamicin treatment and outcome","volume":"127","author":"Dahl","year":"2013","journal-title":"Circulation."},{"key":"10.1016\/j.medcli.2017.03.009_bib0180","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.ijantimicag.2010.11.029","article-title":"Clinical implications of beta-lactam-aminoglycoside synergism: Systematic review of randomised trials","volume":"37","author":"Marcus","year":"2011","journal-title":"Int J Antimicrob Agents."},{"issue":"Suppl 1","key":"10.1016\/j.medcli.2017.03.009_bib0185","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1016\/S0924-8579(13)70097-9","article-title":"The prolonged use of once daily aminoglycosides is safe and effective in the treatment of enterococcal endocarditis","volume":"41","author":"Patrat-Delon","year":"2013","journal-title":"Int J Antimicrob Agents."},{"key":"10.1016\/j.medcli.2017.03.009_bib0190","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.ejim.2008.12.017","article-title":"In infectious endocarditis patients mortality is highly related to kidney function at time of diagnosis: A prospective observational cohort study of 231 cases","volume":"20","author":"Buchholtz","year":"2009","journal-title":"Eur J Intern Med."},{"key":"10.1016\/j.medcli.2017.03.009_bib0195","first-page":"96","article-title":"Predictors of prognosis and risk of acute renal failure in bacterial endocarditis","volume":"49","author":"Conlon","year":"1998","journal-title":"Clin Nephrol."},{"key":"10.1016\/j.medcli.2017.03.009_bib0200","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1093\/cid\/cit052","article-title":"Ampicillin plus ceftriaxone is as effective as ampicillin plus gentamicin for treating enterococcus faecalis infective endocarditis","volume":"56","author":"Fern\u00e1ndez-Hidalgo","year":"2013","journal-title":"Clin Infect Dis."},{"key":"10.1016\/j.medcli.2017.03.009_bib0205","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.ejim.2014.05.011","article-title":"Epidemiology of infective endocarditis in a tertiary-center in Jerusalem: A 3-year prospective survey","volume":"25","author":"Korem","year":"2014","journal-title":"Eur J Intern Med."},{"key":"10.1016\/j.medcli.2017.03.009_bib0210","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.ahj.2011.07.014","article-title":"Prospective study of infective endocarditis from a developing country","volume":"162","author":"Math","year":"2011","journal-title":"Am Heart J."},{"key":"10.1016\/j.medcli.2017.03.009_bib0215","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1053\/j.ackd.2006.04.004","article-title":"Infectious complications in chronic kidney disease","volume":"13","author":"Naqvi","year":"2006","journal-title":"Adv Chronic Kidney Dis."},{"key":"10.1016\/j.medcli.2017.03.009_bib0220","doi-asserted-by":"crossref","first-page":"6213","DOI":"10.1128\/AAC.01563-13","article-title":"High-dose daptomycin therapy for left-sided infective endocarditis: A prospective study from the international collaboration on endocarditis","volume":"57","author":"Carugati","year":"2013","journal-title":"Antimicrob Agents Chemother."},{"key":"10.1016\/j.medcli.2017.03.009_bib0225","doi-asserted-by":"crossref","first-page":"5243","DOI":"10.1016\/j.ijcard.2013.08.023","article-title":"Age adjusted Charlson Co-morbidity Index is an independent predictor of mortality over long-term follow-up in infective endocarditis","volume":"168","author":"Lu","year":"2013","journal-title":"Int J Cardiol."},{"key":"10.1016\/j.medcli.2017.03.009_bib0230","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/1471-2334-11-48","article-title":"Increasing incidence and mortality of infective endocarditis: A population-based study through a record-linkage system","volume":"11","author":"Fedeli","year":"2011","journal-title":"BMC Infect Dis."},{"key":"10.1016\/j.medcli.2017.03.009_bib0235","doi-asserted-by":"crossref","first-page":"e82665","DOI":"10.1371\/journal.pone.0082665","article-title":"Infective endocarditis epidemiology over five decades: A systematic review","volume":"8","author":"Slipczuk","year":"2013","journal-title":"PLoS One."},{"key":"10.1016\/j.medcli.2017.03.009_bib0240","first-page":"728","article-title":"Epidemiology of infective endocarditis in Spain in the last 20 years","volume":"66","author":"Fernandez-Hidalgo","year":"2013","journal-title":"Rev Esp Cardiol (Engl Ed)."},{"key":"10.1016\/j.medcli.2017.03.009_bib0245","first-page":"78","article-title":"Prevalence of chronic renal disease in Spain: Results of the EPIRCE study","volume":"30","author":"Otero","year":"2010","journal-title":"Nefrologia."},{"key":"10.1016\/j.medcli.2017.03.009_bib0250","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1002\/phar.1488","article-title":"Vancomycin-associated renal dysfunction: Where are we now?","volume":"34","author":"Carreno","year":"2014","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.medcli.2017.03.009_bib0255","doi-asserted-by":"crossref","first-page":"4263","DOI":"10.1093\/ndt\/gfs375","article-title":"A European Renal Best Practice (ERBP) position statement on the Kidney Disease Improving Global Outcomes (KDIGO) clinical practice guidelines on acute kidney injury: Part 1: Definitions, conservative management and contrast-induced nephropathy","volume":"27","author":"Fliser","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.medcli.2017.03.009_bib0260","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1086\/600877","article-title":"Vancomycin therapeutic guidelines: A summary of consensus recommendations from the Infectious Diseases Society of America, the American Society of Health-System Pharmacists, and the Society of Infectious Diseases Pharmacists","volume":"49","author":"Rybak","year":"2009","journal-title":"Clin Infect Dis."}],"container-title":["Medicina Cl\u00ednica"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775317302300?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775317302300?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,2]],"date-time":"2018-09-02T12:20:48Z","timestamp":1535890848000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025775317302300"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":26,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["S0025775317302300"],"URL":"https:\/\/doi.org\/10.1016\/j.medcli.2017.03.009","relation":{},"ISSN":["0025-7753"],"issn-type":[{"value":"0025-7753","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Etiolog\u00eda de la insuficiencia renal en pacientes con endocarditis infecciosa. Papel de los antibi\u00f3ticos","name":"articletitle","label":"Article Title"},{"value":"Medicina Cl\u00ednica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.medcli.2017.03.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}